In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The price of Zai Lab Limited ADR (NASDAQ: ZLAB) closed at $26.77 in the last session, down -2.23% from day before closing price of $27.38. In other words, the price has decreased by -$2.23 from its previous closing price. On the day, 0.83 million shares were traded. ZLAB stock price reached its highest trading level at $28.35 during the session, while it also had its lowest trading level at $26.58.
Ratios:
We take a closer look at ZLAB’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.87 and its Current Ratio is at 3.01. In the meantime, Its Debt-to-Equity ratio is 0.19 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Morgan Stanley on December 14, 2023, initiated with a Overweight rating and assigned the stock a target price of $47.50.
On August 10, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $70.
On January 21, 2022, Macquarie started tracking the stock assigning a Outperform rating and target price of $64.Macquarie initiated its Outperform rating on January 21, 2022, with a $64 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jul 01 ’24 when Chen Kai-Xian sold 7,750 shares for $17.22 per share. The transaction valued at 133,455 led to the insider holds 60,778 shares of the business.
Amado Rafael sold 7,583 shares of ZLAB for $199,289 on Dec 31 ’24. The insider now owns 33,834 shares after completing the transaction at $26.28 per share. On Dec 31 ’24, another insider, Amado Rafael, who serves as the Officer of the company, bought 7,583 shares for $26.28 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZLAB now has a Market Capitalization of 3082110464 and an Enterprise Value of 25789376512. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.20 while its Price-to-Book (P/B) ratio in mrq is 3.95. Its current Enterprise Value per Revenue stands at 72.493 whereas that against EBITDA is -78.885.
Stock Price History:
The Beta on a monthly basis for ZLAB is 1.12, which has changed by 0.39267552 over the last 52 weeks, in comparison to a change of 0.2000997 over the same period for the S&P500. Over the past 52 weeks, ZLAB has reached a high of $36.60, while it has fallen to a 52-week low of $13.48. The 50-Day Moving Average of the stock is 0.29%, while the 200-Day Moving Average is calculated to be 19.87%.
Shares Statistics:
According to the various share statistics, ZLAB traded on average about 830.65K shares per day over the past 3-months and 614800 shares per day over the past 10 days. A total of 108.94M shares are outstanding, with a floating share count of 108.70M. Insiders hold about 0.21% of the company’s shares, while institutions hold 44.80% stake in the company. Shares short for ZLAB as of 1736899200 were 6051368 with a Short Ratio of 7.29, compared to 1734048000 on 5845957. Therefore, it implies a Short% of Shares Outstanding of 6051368 and a Short% of Float of 6.3200004000000005.
Earnings Estimates
The current rating of Zai Lab Limited ADR (ZLAB) reflects the combined expertise of 5.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is -$0.56, with high estimates of -$0.56 and low estimates of -$0.56.
Analysts are recommending an EPS of between -$2.26 and -$3.13 for the fiscal current year, implying an average EPS of -$2.72. EPS for the following year is -$1.79, with 9.0 analysts recommending between -$1.07 and -$2.46.
Revenue Estimates
According to 5 analysts, the current quarter’s revenue is expected to be $108.53M. It ranges from a high estimate of $114.47M to a low estimate of $104.5M. As of the current estimate, Zai Lab Limited ADR’s year-ago sales were $65.83MFor the next quarter, 5 analysts are estimating revenue of $112.3M. There is a high estimate of $112.3M for the next quarter, whereas the lowest estimate is $112.3M.
A total of 13 analysts have provided revenue estimates for ZLAB’s current fiscal year. The highest revenue estimate was $404.39M, while the lowest revenue estimate was $365M, resulting in an average revenue estimate of $392.67M. In the same quarter a year ago, actual revenue was $266.72MBased on 14 analysts’ estimates, the company’s revenue will be $576.95M in the next fiscal year. The high estimate is $666.9M and the low estimate is $480M.
